Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein
暂无分享,去创建一个
T. Pawson | R. Cardiff | E. Andrechek | W. Muller | R. Daly | P. Siegel | M. Rauh | V. Blackmore | Christopher G. Tortorice | V. K. Lai | Venus Ka-Man Lai
[1] M. Shibuya,et al. Shc Regulates Epidermal Growth Factor-induced Activation of the JNK Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[2] M. Shibuya,et al. Shc Regulates Epidermal Growth Factor-induced Activation of the JNK Signaling Pathway* , 1999, The Journal of Biological Chemistry.
[3] R. Cardiff,et al. Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.
[4] R. Cardiff,et al. Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.
[5] Tony Pawson,et al. Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.
[6] Tony Pawson,et al. Mammalian Grb2 Regulates Multiple Steps in Embryonic Development and Malignant Transformation , 1998, Cell.
[7] W. Birchmeier,et al. Reconstitution of Mammary Gland Development In Vitro: Requirement of c-met and c-erbB2 Signaling for Branching and Alveolar Morphogenesis , 1998, The Journal of cell biology.
[8] W. Birchmeier,et al. Reconstitution of Mammary Gland Development In Vitro: Requirement of c-met and c-erbB2 Signaling for Branching and Alveolar Morphogenesis , 1998, The Journal of cell biology.
[9] John N. Hutchinson,et al. Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.
[10] Requirement for Both Shc and Phosphatidylinositol 3′ Kinase Signaling Pathways in Polyomavirus Middle T-Mediated Mammary Tumorigenesis , 1998, Molecular and Cellular Biology.
[11] L. Hennighausen,et al. Think globally, act locally: the making of a mouse mammary gland. , 1998, Genes & development.
[12] L. Hennighausen,et al. Think globally, act locally: the making of a mouse mammary gland. , 1998, Genes & development.
[13] G. Rijksen,et al. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens , 1997, The Journal of pathology.
[14] G. Rijksen,et al. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens , 1997, The Journal of pathology.
[15] M. Moran,et al. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation , 1997, Molecular and cellular biology.
[16] M. Moran,et al. Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation , 1997, Molecular and cellular biology.
[17] D. Birnbaum,et al. The Role of the Shc Phosphotyrosine Interaction/Phosphotyrosine Binding Domain and Tyrosine Phosphorylation Sites in Polyoma Middle T Antigen-mediated Cell Transformation* , 1997, The Journal of Biological Chemistry.
[18] D. Birnbaum,et al. The Role of the Shc Phosphotyrosine Interaction/Phosphotyrosine Binding Domain and Tyrosine Phosphorylation Sites in Polyoma Middle T Antigen-mediated Cell Transformation* , 1997, The Journal of Biological Chemistry.
[19] A. DeFranco,et al. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes , 1997, Molecular and cellular biology.
[20] A. DeFranco,et al. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes , 1997, Molecular and cellular biology.
[21] M. Shibuya,et al. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation , 1997, Molecular and cellular biology.
[22] M. Shibuya,et al. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation , 1997, Molecular and cellular biology.
[23] Tony Pawson,et al. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein–protein interactions , 1996, Current Biology.
[24] Tony Pawson,et al. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein–protein interactions , 1996, Current Biology.
[25] P. Pandolfi,et al. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. , 1996, Oncogene.
[26] P. Pandolfi,et al. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. , 1996, Oncogene.
[27] P G Pelicci,et al. Not all Shc's roads lead to Ras. , 1996, Trends in biochemical sciences.
[28] P G Pelicci,et al. Not all Shc's roads lead to Ras. , 1996, Trends in biochemical sciences.
[29] P. Leder,et al. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. , 1996, Oncogene.
[30] P. Leder,et al. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. , 1996, Oncogene.
[31] R. Cardiff,et al. Activated neu Induces Rapid Tumor Progression (*) , 1996, The Journal of Biological Chemistry.
[32] R. Cardiff,et al. Activated neu Induces Rapid Tumor Progression (*) , 1996, The Journal of Biological Chemistry.
[33] M. Shibuya,et al. The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner. , 1995, Oncogene.
[34] M. Shibuya,et al. The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner. , 1995, Oncogene.
[35] P. Pelicci,et al. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. , 1995, Oncogene.
[36] P. Pelicci,et al. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. , 1995, Oncogene.
[37] M. Borrello,et al. Constitutive phosphorylation of Shc proteins in human tumors. , 1995, Oncogene.
[38] M. Borrello,et al. Constitutive phosphorylation of Shc proteins in human tumors. , 1995, Oncogene.
[39] B. Margolis,et al. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor , 1995, Molecular and cellular biology.
[40] B. Margolis,et al. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor , 1995, Molecular and cellular biology.
[41] T. Pawson,et al. The PTB domain: a new protein module implicated in signal transduction. , 1995, Trends in biochemical sciences.
[42] T. Pawson,et al. The PTB domain: a new protein module implicated in signal transduction. , 1995, Trends in biochemical sciences.
[43] A. deFazio,et al. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. , 1994, Oncogene.
[44] A. deFazio,et al. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. , 1994, Oncogene.
[45] R. Sutherland,et al. Overexpression of the Grb2 gene in human breast cancer cell lines. , 1994, Oncogene.
[46] R. Sutherland,et al. Overexpression of the Grb2 gene in human breast cancer cell lines. , 1994, Oncogene.
[47] T. Roberts,et al. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[48] T. Roberts,et al. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] T. Pawson,et al. SH2 and SH3 domains in signal transduction. , 1994, Advances in cancer research.
[50] T. Pawson,et al. SH2 and SH3 domains in signal transduction. , 1994, Advances in cancer research.
[51] T. Pawson,et al. Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors , 1993, Molecular and cellular biology.
[52] T. Pawson,et al. Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors , 1993, Molecular and cellular biology.
[53] Nanxin Li,et al. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.
[54] Nanxin Li,et al. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. , 1993, Science.
[55] D. Bar-Sagi,et al. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras , 1993, Nature.
[56] D. Bar-Sagi,et al. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras , 1993, Nature.
[57] A. Ullrich,et al. The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. , 1993, The EMBO journal.
[58] A. Ullrich,et al. The SH2/SH3 domain‐containing protein GRB2 interacts with tyrosine‐phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. , 1993, The EMBO journal.
[59] Sheila M. Thomas,et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.
[60] Sheila M. Thomas,et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.
[61] R. Cardiff,et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[62] R. Cardiff,et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[63] A. Ullrich,et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.
[64] A. Ullrich,et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling , 1992, Cell.
[65] T. Pawson,et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.
[66] T. Pawson,et al. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction , 1992, Cell.
[67] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[68] R. Cardiff,et al. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.
[69] P. Jolicoeur,et al. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene , 1989, Cell.
[70] P. Jolicoeur,et al. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene , 1989, Cell.
[71] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[72] W Godolphin,et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.
[73] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[74] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[75] P. Brûlet,et al. Sequence analysis of murine cytokeratin endo A (no. 8) cDNA. Evidence for mRNA species initiated upstream of the normal 5' end in PCC4 cells. , 1988, Differentiation; research in biological diversity.
[76] P. Brûlet,et al. Sequence analysis of murine cytokeratin endo A (no. 8) cDNA. Evidence for mRNA species initiated upstream of the normal 5' end in PCC4 cells. , 1988, Differentiation; research in biological diversity.
[77] P. Leder,et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.
[78] P. Leder,et al. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.
[79] B. Seed,et al. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[80] B. Seed,et al. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[81] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[82] D. Melton,et al. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.
[83] D. Melton,et al. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.
[84] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[85] G. Hager,et al. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus , 1981, Cell.
[86] G. Hager,et al. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus , 1981, Cell.
[87] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[88] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[89] B. Vonderhaar,et al. Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. , 1979, Endocrinology.
[90] B. Vonderhaar,et al. Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. , 1979, Endocrinology.
[91] E. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.
[92] E. Southern. Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.